OMéDIT Bretagne

What OMéDIT Bretagne does

OMéDIT Bretagne (Observatoire des Médicaments, des Dispositifs médicaux et des Innovations Thérapeutiques de Bretagne) is a regional public health observatory established in 2012 and headquartered at 14 Avenue Yves Thépot, Quimper, France. Operating under the authority of ARS Bretagne (Agence Régionale de Santé Bretagne), the organization provides evidence-based medication management resources, clinical decision-support tools, and e-learning modules to healthcare establishments and professionals across the Brittany region. Its core offerings include the Fiches VOC (Voie Orale Contre le Cancer) information sheets covering 121+ oral anticancer medications in professional and patient versions, the S.LOGAN antidote location database, and interactive e-learning modules covering immunotherapy and vaccination in oncology.

The technology stack centers on a WordPress-based content platform (omeditbretagne.fr) hosting digital tools, training materials, and downloadable resources, supplemented by native mobile applications on iOS (App Store id 1610995137) and Android (Google Play package com.tristanlecoz.FichesVOC). The platform integrates with national drug databases including Claude Bernard, Theriaque, Thesorimed, and VIDAL through the Medicabase referential for prescription interoperability, and connects to France MVS for medication serialization compliance. Documented sub-brands include the Fiches VOC mobile application and the S.LOGAN antidote management tool. Reported scale indicators include a 91.0% generic medication penetration rate in Brittany as of April 2023.

OMéDIT Bretagne does not operate a commercial revenue model: all resources and tools are provided free of charge to users, with the organization funded through ARS Bretagne appropriations. Its go-to-market is relationship-driven, relying on inter-regional collaborations with peer OMEDIT entities (Normandie, Pays de la Loire, Ile-de-France), poison control centers (Centre Anti-Poison d'Angers), and professional bodies (URPS Pharmaciens de Bretagne, OncoBretagne, Assurance Maladie). The customer base spans hospitals, emergency departments, community pharmacies, and individual healthcare professionals, all within the Brittany region.

Name

OMéDIT Bretagne

Legal name

OMéDIT Bretagne

Website

https://omeditbretagne.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

OMéDIT Bretagne is a French regional public health observatory providing evidence-based medication management resources, clinical decision-support tools, and e-learning modules to healthcare establishments and professionals across the Brittany region.

Ownership category

akta.pro rank

Headquarters

HQ city

Quimper

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

OMéDIT Bretagne is a publicly funded regional health observatory that develops and disseminates evidence-based medication management resources, clinical decision-support databases, and e-learning modules for healthcare establishments and professionals across the Bretagne region of France. Its core deliverables include the S.LOGAN antidote location database, the Fiches VOC oral anticancer medication information sheets (with dedicated mobile apps), the La Juste Prescription prescribing guidance system, antimicrobial stewardship tools (CONSORES, A.B.R.I), and CAQES regulatory coordination services. All resources are provided free of charge under the strategic authority of ARS Bretagne.

Differentiator

Problem solved

Functional benefit

Brands

• Fiches VOC Application: Mobile application for accessing oral anticancer medication information sheets (Fiche Voie Orale contre le Cancer) for patients and healthcare professionals.
• S.LOGAN

Products and services

• S.LOGAN (Site de Localisation et de Gestion des Antidotes) Free database tool for locating antidote stocks in Breton healthcare establishments, designed to help emergency physicians and poison control centers optimize pre-hospital patient care during intoxication cases.
• Fiches VOC (Voie Orale Contre le Cancer) Comprehensive information sheets on oral anticancer medications for healthcare professionals and patients, covering dosing, side effects, administration, and monitoring protocols, with professional and patient versions in multiple languages. Includes a dedicated mobile application for iOS and Android.
• La Juste Prescription Comprehensive medication prescribing guidance database adopted from OMéDIT Île-de-France and promoted regionally by OMéDIT Bretagne to support appropriate prescribing practices.
• Immunotherapy E-learning Module Interactive 1h30 training module for healthcare professionals on identifying, managing, and preventing immunotherapy side effects in oncology patients.
• CAQES Contract Coordination (Contrat d'Amélioration de la Qualité et de l'Efficience des Soins) Official regional observatory coordination role for CAQES quality contracts, supporting Breton healthcare establishments in regulatory compliance monitoring.
• CONSORES E-tool (Antimicrobial Stewardship) Digital tool for antimicrobial stewardship and infectious disease management used within OMéDIT Bretagne's infectiology program.
• A.B.R.I (Astr Bretonne Ref Infectiologie) Breton Antibiotic Reference network supporting infectious disease and antibiotic best-practice resources for healthcare professionals in the region.

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• OMéDIT NormandiecoreStrategic or Co-development PartnerInter-regional collaboration partner for developing and maintaining oral anticancer medication information sheets (Fiches VOC). Joint methodology development and content standardization across regions.
• OMéDIT Pays de la LoirecoreStrategic or Co-development PartnerInter-regional collaboration partner for oral anticancer medication information sheets (Fiches VOC) and oncology resources. Shared development of patient follow-up tools and e-learning modules.
• Centre Anti-Poison d'AngerscoreStrategic or Co-development PartnerCollaboration on S.LOGAN antidote location database system. CAPTV Angers provides recommended minimum antidote stock levels and supports regional deployment.
• ARS BretagnecoreStrategic or Co-development PartnerRegional health authority funding and strategic coordination. Supports deployment of S.LOGAN and other OMEDIT tools through official communications to healthcare establishments.
• Assurance MaladieminorOthersCollaboration on generic medication lists and repertoire data. Joint efforts on medication penetration rate tracking and prescription optimization.
• URPS Pharmaciens de BretagneminorStrategic or Co-development PartnerRegional pharmacists union partnership for developing pharmaceutical interview tools and patient follow-up resources for oral anticancer medications.
• OMéDIT Ile-de-FranceminorStrategic or Co-development PartnerSource organization for La Juste Prescription database - comprehensive medication prescribing guidance system adopted and promoted regionally.
• OncoBretagneminorStrategic or Co-development PartnerRegional cancer care network collaboration on oncology e-learning modules and cancer medication management resources.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• OncoBretagne: Regional oncology network for Brittany covering cancer care coordination. Direct peer/partner in oncology medication management and e-learning — collaborates with OMéDIT Bretagne on cancer-related tools.
• OMEDIT Ile-de-France: Regional observatory for the Paris/Ile-de-France region. Source organization for the La Juste Prescription database consumed by OMéDIT Bretagne; same OMEDIT mandate covering a larger population base.
• OMEDIT Nouvelle-Aquitaine: Regional observatory serving Nouvelle-Aquitaine. Comparable role in medication management, drug shortages, and clinical guidance for another large French region — part of the same national OMEDIT ecosystem.
• OMEDIT Pays de la Loire: Regional health observatory for the Pays de la Loire region. Direct peer with identical regulatory mandate covering medication management, oncology resources, and e-learning — explicit co-development partner with OMéDIT Bretagne.
• OMEDIT Normandie: Regional medication/medical device observatory covering Normandy, France. Directly comparable regional OMEDIT peer with co-development partnership on Fiches VOC oral anticancer medication sheets — same mandate, similar scope, adjacent territory.

Broad incumbents

• Haute Autorité de Santé (HAS): National French health authority issuing clinical guidelines and health technology assessments. Overlaps with OMéDIT Bretagne on medication guidance and good-use protocols, but at national scale and with broader scope.
• VIDAL Group: Leading commercial French drug information database provider integrated with OMéDIT Bretagne via Medicabase. A commercial-scale incumbent offering drug monographs, interactions, and decision support that parallels OMéDIT's content mission.
• ANSM (Agence Nationale de Sécurité du Médicament): National French medicines agency regulating pharmaceuticals and medical devices. Operates in adjacent policy, pharmacovigilance, and drug safety domains — broader mandate but overlapping authority with regional OMEDIT observatories.

Others

• RESOMEDIT: National network that coordinates the regional OMEDIT observatories across France. Provides the inter-regional framework that OMéDIT Bretagne operates within, including joint working groups on medico-economics and oncology (Travaux RESOMEDIT).

Emerging players

• Centre Anti-Poison d'Angers (CAP Angers): Regional poison control center that co-developed the S.LOGAN antidote database with OMéDIT Bretagne. Specializes in toxicology and antidote guidance — comparable to OMéDIT Bretagne's high-risk medication focus but with a narrower clinical scope.

Market position

Weaknesses5 records

Competitive moat4 records

Customer concentration

• YouTubeyoutube.com/channel/UCYZqG0FNRRK2LfKDjcE5vKg
• LinkedInlinkedin.com/company/om%C3%A9dit-bretagne

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OMéDIT Bretagne